FDA Issues Warning Over Eye Drops Claiming to Treat Cataracts, Glaucoma
FDA Issues Warning Over Eye Drops Claiming to Treat Cataracts, Glaucoma The Food and Drug Administration( FDA) transferred advising lettersTrusted Source on this month to CVS, Walgreens and other companies for manufacturing or marketing unapproved eye products that are potentially dangerous to people who use them. The products are immorally retailed to treat conditions similar as conjunctivitis( “ pink eye ”), cataracts, and glaucoma, the agency said. Some of the warning letters also cite quality issues related to the sterility of the products. The FDA issued advising letters to BoironInc.; CVS Health; DR Vitamin results; Natural Ophthalmics,Inc.; OcluMed LLC; Similasan AG/ Similasan USA; TRP Company,Inc.; and Walgreens Boots Alliance,Inc. The agency also placed some of these companies on import alert to help keep their products from entering the United States. “ The FDA is particularly c...